XML 67 R45.htm IDEA: XBRL DOCUMENT v3.20.4
The COVID-19 Pandemic (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 15, 2021
Dec. 04, 2020
Sep. 30, 2020
Apr. 23, 2020
Oct. 31, 2020
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Nov. 03, 2020
Sep. 29, 2020
Apr. 22, 2020
Unusual or Infrequent Item, or Both [Line Items]                        
Change in revenue, percent             (63.50%)          
Change in capacity, percent             48.80%          
Long-term debt, term             364 years          
Loyalty points, pre-purchase arrangement             $ 150,000,000          
Reduction in aircraft capital expenditures through 2022, relating to airbus purchase agreement amendment         $ 2,000,000,000.0              
CARES act, payroll support program, total payment     $ 27,000,000 $ 936,000,000   $ 27,000,000 963,000,000          
Proceeds from sale leaseback transactions             563,000,000          
CARES act, secured loans, eligibility amount             1,900,000,000     $ 1,900,000,000    
Proceeds from issuance of common stock             620,000,000 $ 51,000,000 $ 48,000,000      
Cash, cash equivalents, and short-term investments             3,100,000,000          
Proceeds from sale-leaseback transactions             354,000,000 0 0      
Proceeds from sale-leaseback transactions             209,000,000 0 0      
Losses on sale-leaseback transactions             (106,000,000) 0 0      
Fleet impairment             273,000,000 $ 0 $ 0      
CARES act, payroll support program, grant     $ 19,000,000 $ 685,000,000   $ 19,000,000 $ 704,000,000          
Class of warrant or right, outstanding (in shares)     85,540 2,600,000   85,540 85,540       1,200,000  
Class of warrant or right, exercise price of warrants or rights (in dollars per share)       $ 9.50     $ 9.50       $ 9.50  
Warrants and rights outstanding, term       5 years                
Warrants and rights outstanding             $ 19,000,000          
CARES act, payroll support program, grant, carrying value, total             $ 685,000,000          
CARES act, class of warrant or right, expected (in shares)             20,500,000          
CARES act initial drawing amount                     $ 115,000,000  
Remaining borrowing capacity             $ 1,800,000,000          
CARES act, payroll tax deferral             48,000,000          
Common Stock [Member]                        
Unusual or Infrequent Item, or Both [Line Items]                        
Stock issued during period, shares, new issues (in shares)   42,000,000                    
Proceeds from issuance of common stock             583,000,000          
Subsequent Event                        
Unusual or Infrequent Item, or Both [Line Items]                        
Class of warrant or right, outstanding (in shares) 316,583                      
Class of warrant or right, exercise price of warrants or rights (in dollars per share) $ 14.43                      
CARES act, payroll support program, grant, carrying value, total $ 206,000,000                      
Treasury payment 252,000,000                      
CARES act, payroll support program, grant, loan amount 46,000,000                      
CARES act, payroll support program, grant, carrying value, total 1 252,000,000                      
CARES act, payroll support program, grant, loan amount 1 $ 76,000,000                      
Long-term Debt                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, face amount             $ 923,000,000          
Long-term Debt | Airbus A321                        
Unusual or Infrequent Item, or Both [Line Items]                        
Number of aircraft, secured debt transactions             49          
Morgan Stanley | Short-term Debt                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, face amount             $ 1,000,000,000.0          
Citibank | Citibank line of credit, due through 2023 | Line of Credit                        
Unusual or Infrequent Item, or Both [Line Items]                        
Line of credit, current             550,000,000         $ 550,000,000
Barclays | Floating rate term loan credit facility, due through 2024 | Long-term Debt                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, face amount             750,000,000          
US Department of Treasury | Secured CARES Act Loan, due through 2025 | Long-term Debt                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, face amount             $ 115,000,000       $ 115,000,000  
US Department of Treasury | Unsecured Debt                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, face amount     $ 8,000,000 $ 251,000,000   $ 8,000,000            
Long-term debt, term       10 years                
Debt instrument, interest rate, stated percentage       1.00%                
US Department of Treasury | Unsecured Debt | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate                        
Unusual or Infrequent Item, or Both [Line Items]                        
Debt instrument, basis spread on variable rate       2.00%